G. Steven Burrill

Navigating the Sea of Change

ABSTRACT: Healthcare reform, greentech, climate change, food security, energy needs (and security) and sustainability, these are the big issues dominating the world today with biotech providing the answers to all. Yet, the world has undergone a sea change, it is not the same as it was. Capital is scarce and expensive. Technology has changed the products and market needs. Markets are different and governments are increasingly the customer, regulator and even financier. It's a different world, yet one we must prosper in. Steve Burrill will address the issues and the solutions.

BIO: G. Steven Burrill is Chief Executive Officer of Burrill & Company, a San Francisco based life sciences firm focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, healthcare delivery, nutraceuticals and wellness, agricultural biotechnology, industrial biotechnology (biomaterials/bioprocesses), and biofuels. Burrill & Company's business revolves around four core activities: Venture Capital, Private Equity, Merchant Banking and Media. In our investment activities, Burrill & Company seeks to create value through developing significant equity stakes in its portfolio companies which benefit from Burrill & Company's unparalleled network in the life science community. In addition to the company's staff of over 50, Burrill & Company calls upon the members of its advisory boards for counsel. These boards are composed of former chief executives of major pharmaceutical, and biotech companies; industry luminaries; world-renowned scientists; and Nobel Laureates.